Insider Trading disclosures for CorMedix Inc

The latest disclosure was made by Myron Kaplan in CorMedix Inc where a trade of 25,000 Common Stock done was reported to US exchanges on Jan. 17, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	25,000	176,034 (0%)	0%		0	Common Stock
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	25,000	40,250 (0%)	0%		0	Common Stock
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	25,000	100,498 (0%)	0%		0	Common Stock
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	25,000	78,473 (0%)	0%		0	Common Stock
Gregory Duncan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	25,000	25,000 (0%)	0%		0	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Jan 2025	187,500	495,528 (1%)	0%		0	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.17 per share.	17 Jan 2025	23,977	471,551 (1%)	0%	12.2	291,800	Common Stock
Elizabeth Hurlburt	EVP	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share.	10 Jan 2025	5,790	115,728 (0%)	0%	11.2	64,790	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share.	10 Jan 2025	17,829	308,028 (1%)	0%	11.2	199,507	Common Stock
Matthew T. David	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share.	10 Jan 2025	6,515	95,270 (0%)	0%	11.2	72,903	Common Stock
Erin Mistry	EVP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.19 per share.	10 Jan 2025	5,689	100,992 (0%)	0%	11.2	63,660	Common Stock
Elizabeth Hurlburt	EVP	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	87,500	132,897 (0%)	0%		0	Common Stock
Elizabeth Hurlburt	EVP	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.22 per share.	02 Jan 2025	11,378	121,519 (0%)	0%	8.2	93,527	Common Stock
Matthew T. David	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	62,500	110,434 (0%)	0%		0	Common Stock
Matthew T. David	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.22 per share.	02 Jan 2025	8,648	101,786 (0%)	0%	8.2	71,087	Common Stock
Erin Mistry	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	62,500	114,511 (0%)	0%		0	Common Stock
Erin Mistry	EVP, Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.22 per share.	02 Jan 2025	7,830	106,681 (0%)	0%	8.2	64,363	Common Stock
Beth Zelnick Kaufman	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Jan 2025	87,500	131,456 (0%)	0%		0	Common Stock
Beth Zelnick Kaufman	Chief Legal Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.22 per share.	02 Jan 2025	11,844	119,612 (0%)	0%	8.2	97,358	Common Stock
Beth Kaufman Zelnick	Chief Legal Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.77 per share.	16 Dec 2024	6,044	43,956 (0%)	0%	8.8	53,006	Common Stock
Beth Zelnick Kaufman	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Dec 2024	12,500	62,500 (0%)	0%		-	Common Stock
Beth Zelnick Kaufman	Chief Legal Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Dec 2024	12,500	37,500	-		-	Restricted Stock Units
Beth Zelnick Kaufman	Chief Legal Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.77 per share.	12 Dec 2024	6,044	56,456 (0%)	0%	8.8	53,006	Common Stock
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.33 per share.	14 Nov 2024	3	45,400 (0%)	0%	1.3	4	Common Stock
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Nov 2024	25,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Nov 2024	62,500	62,500	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Nov 2024	34,467	3,033	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Nov 2024	9,888	27,612	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Nov 2024	8,169	12,711	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	14 Nov 2024	3	53,997	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Hurlburt	EVP	Sale of securities on an exchange or to another person at price $ 11.18 per share.	14 Nov 2024	140,027	45,397 (0%)	0%	11.2	1,565,670	Common Stock
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.47 per share.	14 Nov 2024	25,000	185,424 (0%)	0%	3.5	86,750	Common Stock
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.43 per share.	14 Nov 2024	62,500	160,424 (0%)	0%	4.4	276,875	Common Stock
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.08 per share.	14 Nov 2024	34,467	97,924 (0%)	0%	4.1	140,625	Common Stock
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.63 per share.	14 Nov 2024	9,888	63,457 (0%)	0%	5.6	55,669	Common Stock
Elizabeth Hurlburt	EVP	Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.30 per share.	14 Nov 2024	8,169	53,569 (0%)	0%	8.3	67,803	Common Stock
Erin Mistry	EVP, Chief Commercial Officer	Purchase of securities on an exchange or from another person at price $ 9.99 per share.	31 Oct 2024	1,500	52,011 (0%)	0%	10.0	14,985	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.17 per share.	10 May 2024	26,982	325,857 (1%)	0%	5.2	139,497	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 3.74 per share.	13 Mar 2024	13,561	352,839 (1%)	0%	3.7	50,718	Common Stock
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2024	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2024	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2024	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2024	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Gregory Duncan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	05 Mar 2024	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Erin Mistry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2024	50,000	54,900 (0%)	0%		0	Common Stock
David Matthew T.	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2024	100,000	100,000	-		-	Stock Option (Right to Buy Common Stock)
Todisco Joseph	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2024	266,667	266,667	-		-	Stock Option (Right to Buy Common Stock)
Todisco Joseph	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2024	133,333	353,059 (1%)	0%		0	Common Stock
David T. Matthew	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2024	50,000	53,150 (0%)	0%		0	Common Stock
Mistry Erin	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jan 2024	100,000	100,000	-		-	Stock Option (Right to Buy Common Stock)
Matthew T. David	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share.	12 Jan 2024	5,216	47,934 (0%)	0%	3.5	18,100	Common Stock
Erin Mistry	Chief Commercial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share.	12 Jan 2024	4,389	50,511 (0%)	0%	3.5	15,230	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.47 per share.	12 Jan 2024	13,781	339,278 (1%)	0%	3.5	47,820	Common Stock
Alan Dunton W.	Director	Purchase of securities on an exchange or from another person at price $ 3.45 per share.	14 Dec 2023	3,000	12,250 (0%)	0%	3.5	10,350	Common Stock
W. Dunton Alan	Director	Purchase of securities on an exchange or from another person at price $ 3.30 per share.	14 Dec 2023	3,000	15,250 (0%)	0%	3.3	9,900	Common Stock
Beth Kaufman Zelnick	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2023	50,000	50,000 (0%)	0%		0	Common Stock
Kaufman Beth Zelnick	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Dec 2023	200,000	200,000	-		-	Stock Option (Right to Buy Common Stock)
Alan W. Dunton	Director	Purchase of securities on an exchange or from another person at price $ 4.33 per share.	17 May 2023	3,000	9,250 (0%)	0%	4.3	12,980	Common Stock
Paulo F. Costa	Director	Purchase of securities on an exchange or from another person at price $ 4.65 per share.	17 May 2023	10,000	10,000 (0%)	0%	4.7	46,500	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 4.58 per share.	17 May 2023	5,000	209,726 (0%)	0%	4.6	22,900	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.30 per share.	10 May 2023	37,443	204,726 (0%)	0%	5.3	198,448	Common Stock
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Paulo F. Costa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Gregory Duncan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Hurlburt	EVP, Head of Clinical Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	125,000	125,000	-		-	Stock Option (Right to Buy Common Stock)
Phoebe Mounts	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	125,000	125,000	-		-	Stock Option (Right to Buy Common Stock)
Joseph Todisco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	400,000	400,000	-		-	Stock Option (Right to Buy Common Stock)
Matthew T. David	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	125,000	125,000	-		-	Stock Option (Right to Buy Common Stock)
Erin Mistry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Jan 2023	75,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Joseph Todisco	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 3.82 per share.	15 Nov 2022	20,000	242,169 (0%)	0%	3.8	76,400	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 3.92 per share.	24 Aug 2022	4,700	222,169 (0%)	0%	3.9	18,424	Common Stock
Myron Kaplan	Director	Purchase of securities on an exchange or from another person at price $ 3.78 per share.	17 May 2022	5,000	160,034 (0%)	0%	3.8	18,900	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 3.38 per share.	16 May 2022	10,000	217,469 (0%)	0%	3.4	33,800	Common Stock
Joseph Todisco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	500,000	500,000	-		-	Stock Option (Right to Buy Common Stock)
Joseph Todisco	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 May 2022	207,469	207,469 (0%)	0%		0	Common Stock
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2022	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2022	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2022	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Paulo F. Costa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2022	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2022	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Greg Duncan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2022	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Masson	EVP, Head of Clinical Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Feb 2022	100,000	100,000	-		-	Stock Option (Right to Buy Common Stock)
Phoebe Mounts	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Feb 2022	140,000	140,000	-		-	Stock Option (Right to Buy)
Thomas Nusbickel	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	18 Feb 2022	100,000	100,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	Director	Gift of securities by or to the insider at price $ 0.00 per share.	27 Dec 2021	20,000	155,034 (0%)	0%		0	Common Stock
Myron Kaplan	Director	Gift of securities by or to the insider at price $ 0.00 per share.	27 Dec 2021	5,000	140,034 (0%)	0%		0	Common Stock
Myron Kaplan	Director	Gift of securities by or to the insider at price $ 0.00 per share.	27 Dec 2021	5,000	145,034 (0%)	0%		0	Common Stock
Myron Kaplan	Director	Gift of securities by or to the insider at price $ 0.00 per share.	27 Dec 2021	5,000	150,034 (0%)	0%		0	Common Stock
Matthew David	Interim CEO and CFO	Purchase of securities on an exchange or from another person at price $ 5.07 per share.	17 Nov 2021	1,000	2,150 (0%)	0%	5.1	5,070	Common Stock
Myron Kaplan	Director	Purchase of securities on an exchange or from another person at price $ 5.14 per share.	16 Nov 2021	10,000	175,034 (0%)	0%	5.1	51,400	Common Stock
Matthew David	Interim CEO and CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Nov 2021	125,000	125,000	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Masson	EVP, Head of Clinical Ops	Sale of securities on an exchange or to another person at price $ 6.92 per share.	21 May 2021	8,000	0 (0%)	0%	6.9	55,394	Common Stock
Myron Kaplan	Director	Purchase of securities on an exchange or from another person at price $ 6.03 per share.	17 May 2021	15,000	165,034 (0%)	0%	6.0	90,477	Common Stock
Thomas Nusbickel	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2021	7,500	7,500	-		-	Stock Option (Right to Buy Common Stock)
Thomas Nusbickel	EVP, Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2021	260,000	260,000	-		-	Stock Option (Right to Buy Common Stock)
John L. Armstrong	Exec VP of Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	140,000	140,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Paulo F. Costa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	30,000	30,000	-		-	Stock Option (Right to Buy Common Stock)
Greg Duncan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	320,000	320,000	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Masson	EVP, Head of Clinical Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	140,000	140,000	-		-	Stock Option (Right to Buy Common Stock)
Phoebe Mounts	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	140,000	140,000	-		-	Stock Option (Right to Buy Common Stock)
Matthew David	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 Jan 2021	80,000	80,000	-		-	Stock Option (Right to Buy Common Stock)
Greg Duncan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Greg Duncan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Nov 2020	2,500	2,500	-		-	Stock Option (Right to Buy Common Stock)
Paulo F. Costa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Sep 2020	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Paulo F. Costa	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Sep 2020	3,750	3,750	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	Director	Purchase of securities on an exchange or from another person at price $ 4.00 per share.	04 Sep 2020	3,500	58,283 (0%)	0%	4	14,000	Common Stock
Steven W. Lefkowitz	Director	Purchase of securities on an exchange or from another person at price $ 3.98 per share.	04 Sep 2020	2,215	60,498 (0%)	0%	4.0	8,816	Common Stock
Matt David	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 4.07 per share.	03 Sep 2020	1,150	1,150 (0%)	0%	4.1	4,681	Common Stock
Myron Kaplan	Director	Purchase of securities on an exchange or from another person at price $ 4.27 per share.	02 Sep 2020	15,300	150,034 (0%)	0%	4.3	65,359	Common Stock
Mehmood Khan	Director	Purchase of securities on an exchange or from another person at price $ 4.90 per share.	18 Aug 2020	8,433	178,767 (0%)	0%	4.9	41,296	Common Stock
Mehmood Khan	Director	Purchase of securities on an exchange or from another person at price $ 4.91 per share.	18 Aug 2020	9,404	170,334 (0%)	0%	4.9	46,176	Common Stock
Mehmood Khan	Director	Purchase of securities on an exchange or from another person at price $ 4.86 per share.	18 Aug 2020	21,082	160,930 (0%)	0%	4.9	102,366	Common Stock
Mehmood Khan	Director	Purchase of securities on an exchange or from another person at price $ 4.62 per share.	18 Aug 2020	4,500	139,848 (0%)	0%	4.6	20,790	Common Stock
Mehmood Khan	Director	Purchase of securities on an exchange or from another person at price $ 4.60 per share.	18 Aug 2020	2,331	135,348 (0%)	0%	4.6	10,723	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Purchase of securities on an exchange or from another person at price $ 4.35 per share.	14 Aug 2020	10,000	96,878 (0%)	0%	4.3	43,460	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Purchase of securities on an exchange or from another person at price $ 4.14 per share.	14 Aug 2020	7,500	86,878 (0%)	0%	4.1	31,050	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Purchase of securities on an exchange or from another person at price $ 4.16 per share.	14 Aug 2020	10,000	79,378 (0%)	0%	4.2	41,600	Common Stock
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Aug 2020	4,770	4,770	-		-	Phantom Stock
Myron Kaplan	Director	Purchase of securities on an exchange or from another person at price $ 4.08 per share.	13 Aug 2020	15,000	134,734 (0%)	0%	4.1	61,160	Common Stock
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 4.14 per share.	13 Aug 2020	4,830	60,905 (0%)	0%	4.1	19,985	Common Stock
Phoebe Mounts	General Counsel	Purchase of securities on an exchange or from another person at price $ 4.03 per share.	13 Aug 2020	2,525	7,200 (0%)	0%	4.0	10,176	Common Stock
Alan W. Dunton	Director	Purchase of securities on an exchange or from another person at price $ 3.95 per share.	12 Aug 2020	5,000	6,250 (0%)	0%	4.0	19,750	Common Stock
Myron Kaplan	Director	Purchase of securities on an exchange or from another person at price $ 3.85 per share.	15 May 2020	10,000	119,734 (0%)	0%	3.9	38,500	Common Stock
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2020	5,253	5,253	-		-	Phantom Stock
John L. Armstrong	Exec VP of Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 May 2020	37,500	37,500	-		-	Stock Option (Right to Buy Common Stock)
John L. Armstrong	Exec VP of Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 May 2020	37,500	37,500	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Masson	EVP, Head of Clinical Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 May 2020	37,500	37,500	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Masson	EVP, Head of Clinical Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 May 2020	37,500	37,500	-		-	Stock Option (Right to Buy Common Stock)
Phoebe Mounts	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 May 2020	50,000	50,000	-		-	Stock Option (Right to Buy Common Stock)
Phoebe Mounts	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 May 2020	50,000	50,000	-		-	Stock Option (Right to Buy Common Stock)
Matt David	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 May 2020	125,000	125,000	-		-	Stock Option (Right to Buy Common Stock)
Matt David	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	11 May 2020	125,000	125,000	-		-	Stock Option (Right to Buy Common Stock)
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 2.61 per share.	18 Mar 2020	3,500	56,075 (0%)	0%	2.6	9,135	Common Stock
Phoebe Mounts	General Counsel	Purchase of securities on an exchange or from another person at price $ 3.05 per share.	18 Mar 2020	3,250	4,675 (0%)	0%	3.1	9,913	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2020	24,764	24,764	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2020	15,000	15,000	-		-	Stock Option (Right to Buy Common Stock)
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2020	15,000	15,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2020	15,000	15,000	-		-	Stock Option (Right to Buy Common Stock)
Mehmood Khan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2020	15,000	15,000	-		-	Stock Option (Right to Buy Common Stock)
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2020	100,630	100,630	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Masson	EVP, Head of Clinical Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2020	24,764	24,764	-		-	Stock Option (Right to Buy Common Stock)
Phoebe Mounts	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Feb 2020	24,764	24,764	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Feb 2020	1,706	1,706	-		-	Phantom Stock
Steven W. Lefkowitz	Director		07 Jan 2020	3,000	3,000	-		-	Warrant (Right to Purchase Common Stock)
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	07 Jan 2020	15,000	15,000	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	Director		07 Jan 2020	4,500	59,776 (0%)	0%	4.5	20,250	Common Stock
Steven W. Lefkowitz	Director		07 Jan 2020	4,500	4,500	-		-	Warrant (Right to Purchase Common Stock)
Steven W. Lefkowitz	Director		07 Jan 2020	3,000	30,152 (0%)	0%	4.5	13,500	Common Stock
Phoebe Mounts	General Counsel	Purchase of securities on an exchange or from another person at price $ 7.04 per share.	30 Dec 2019	1,425	1,425 (0%)	0%	7.0	10,038	Common Stock
Mehmood Khan	Director	Purchase of securities on an exchange or from another person at price $ 6.58 per share.	13 Dec 2019	17,000	133,017 (0%)	0%	6.6	111,925	Common Stock
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Nov 2019	2,099	2,099	-		-	Phantom Stock
Myron Kaplan	Director	Purchase of securities on an exchange or from another person at price $ 6.81 per share.	30 Sep 2019	5,000	109,734 (0%)	0%	6.8	34,050	Common Stock
Robert W. Cook	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 6.88 per share.	30 Sep 2019	1,000	27,517 (0%)	0%	6.9	6,879	Common Stock
Steven W. Lefkowitz	Director	Purchase of securities on an exchange or from another person at price $ 6.75 per share.	27 Sep 2019	5,000	55,276 (0%)	0%	6.8	33,750	Common Stock
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	26 Sep 2019	120,000	120,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	Director	Purchase of securities on an exchange or from another person at price $ 8.06 per share.	16 Aug 2019	6,000	104,734 (0%)	0%	8.1	48,360	Common Stock
Robert W. Cook	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 8.18 per share.	16 Aug 2019	1,000	26,517 (0%)	0%	8.2	8,180	Common Stock
Robert W. Cook	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 8.18 per share.	16 Aug 2019	1,000	26,517 (0%)	0%	8.2	8,180	Common Stock
Janet M. Dillione	Director	Purchase of securities on an exchange or from another person at price $ 8.19 per share.	14 Aug 2019	6,147	53,473 (0%)	0%	8.2	50,344	Common Stock
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Aug 2019	945	945	-		-	Phantom Stock
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2019	7,500	7,500	-		-	Stock Option (Right to Buy Common Stock)
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Jul 2019	1,250	1,250 (0%)	0%		-	Restricted Stock Units
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2019	1,126	226	-		-	Phantom Stock
Janet M. Dillione	Director	Purchase of securities on an exchange or from another person at price $ 6.74 per share.	15 May 2019	11,144	47,326 (0%)	0%	6.7	75,111	Common Stock
Phoebe Mounts	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 May 2019	70,000	70,000	-		-	Stock Option (Right to Buy Common Stock)
Robert W. Cook	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 9.35 per share.	29 Mar 2019	100	25,517 (0%)	0%	9.4	935	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Purchase of securities on an exchange or from another person at price $ 7.73 per share.	26 Mar 2019	5,000	69,378 (0%)	0%	7.7	38,650	Common Stock
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 7.55 per share.	26 Mar 2019	2,500	52,575 (0%)	0%	7.6	18,875	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Purchase of securities on an exchange or from another person at price $ 1.69 per share.	25 Mar 2019	15,000	321,890 (1%)	0%	1.7	25,350	Common Stock
Janet M. Dillione	Director	Purchase of securities on an exchange or from another person at price $ 1.67 per share.	18 Mar 2019	42,000	180,909 (0%)	0%	1.7	69,972	Common Stock
Alan W. Dunton	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2019	20,000	20,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Feb 2019	4,213	4,213	-		-	Phantom Stock
John L. Armstrong	Exec VP of Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	45,000	45,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	75,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	5,000	473,666 (0%)	0%		-	Restricted Stock Units
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	10,000	468,666 (0%)	0%		-	Restricted Stock Units
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	15,000	458,666 (0%)	0%		-	Restricted Stock Units
Myron Kaplan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	12,500	443,666 (0%)	0%		-	Restricted Stock Units
Robert W. Cook	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	100,000	100,000	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	75,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	12,500	233,879 (0%)	0%		-	Restricted Stock Units
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	7,500	241,379 (0%)	0%		-	Restricted Stock Units
Steven W. Lefkowitz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	10,000	251,379 (0%)	0%		-	Restricted Stock Units
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	12,500	133,909 (0%)	0%		-	Restricted Stock Units
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	75,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	5,000	138,909 (0%)	0%		-	Restricted Stock Units
Gary Gelbfish	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	12,500	2,654,871 (0%)	0%		-	Restricted Stock Units
Gary Gelbfish	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	75,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Mehmood Khan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	3,000	580,083 (0%)	0%		-	Restricted Stock Units
Mehmood Khan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	12,500	577,083 (0%)	0%		-	Restricted Stock Units
Mehmood Khan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	75,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	400,000	400,000	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Masson	EVP, Head of Clinical Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2019	120,000	120,000	-		-	Stock Option (Right to Buy Common Stock)
John L. Armstrong	Exec VP of Tech Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2018	18,029	306,890 (0%)	0%		0	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2018	18,029	0	-		-	Restricted Stock Units
Steven W. Lefkowitz	None	Purchase of securities on an exchange or from another person at price $ 1.18 per share.	20 Dec 2018	20,000	135,757 (0%)	0%	1.2	23,500	Common Stock, $0.001 par value per share
Mehmood Khan	None	Purchase of securities on an exchange or from another person at price $ 1.24 per share.	20 Dec 2018	100,000	564,583 (0%)	0%	1.2	124,410	Common Stock
Myron Kaplan	None	Purchase of securities on an exchange or from another person at price $ 1.47 per share.	14 Dec 2018	50,000	431,166 (0%)	0%	1.5	73,300	Common Stock
Elizabeth Masson	EVP, Head of Clinical Ops.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	05 Dec 2018	40,000	270,000	-		-	Stock Option (Right to Buy Common Stock)
Elizabeth Masson	EVP, Head of Clinical Ops.	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.29 per share.	05 Dec 2018	40,000	40,000 (0%)	0%	0.3	11,600	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Purchase of securities on an exchange or from another person at price $ 1.45 per share.	29 Nov 2018	250,000	288,861 (0%)	0%	1.5	363,150	Common Stock
Robert W. Cook	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 1.17 per share.	27 Nov 2018	25,000	127,083 (0%)	0%	1.2	29,213	Common Stock
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.21 per share.	26 Nov 2018	21,500	250,373 (0%)	0%	1.2	26,015	Common Stock
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 1.28 per share.	26 Nov 2018	3,500	228,873 (0%)	0%	1.3	4,480	Common Stock
Myron Kaplan	None	Purchase of securities on an exchange or from another person at price $ 1.30 per share.	23 Nov 2018	50,000	371,166 (0%)	0%	1.3	64,795	Common Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Nov 2018	6,637	6,637	-		-	Phantom Stock
Myron Kaplan	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Nov 2018	5,000	321,166 (0%)	0%		0	Common Stock
Myron Kaplan	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	06 Nov 2018	5,000	0	-		-	Restricted Stock Units
Gary Gelbfish	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	12 Oct 2018	1,000,000	0	-		-	Series B Common Stock Warrant
Gary Gelbfish	None	Other type of transaction at price $ 0.00 per share.	12 Oct 2018	1,000,000	0	-		-	Series A Common Stock Warrant
Gary Gelbfish	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share.	12 Oct 2018	1,000,000	3,111,121 (3%)	1%	1.1	1,050,000	Common Stock
Gary Gelbfish	None	Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share.	12 Oct 2018	468,750	2,642,371 (2%)	0%	2.2	1,050,000	Common Stock
Myron Kaplan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2018	10,000	316,166 (0%)	0%		0	Restricted Stock Units
Steven W. Lefkowitz	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Oct 2018	10,000	221,379 (0%)	0%		0	Common Stock, $0.001 par value per share
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Aug 2018	13,636	13,636	-		-	Phantom Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2018	37,500	37,500	-		-	Phantom Stock
Elizabeth Masson	EVP, Head of Clinical Ops.	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Mar 2018	310,000	310,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Feb 2018	10,000	294,166 (0%)	0%		0	Common Stock
Myron Kaplan	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Feb 2018	10,000	0	-		-	Restricted Stock Units
Janet M. Dillione	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Feb 2018	15,357	107,409 (0%)	0%		0	Common Stock
Janet M. Dillione	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Feb 2018	15,357	0	-		-	Restricted Stock Units
John L. Armstrong	Exec VP of Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	45,000	45,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	22,000	306,166 (0%)	0%		0	Restricted Stock Units
Myron Kaplan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	40,000	40,000	-		-	Stock Option (Right to Buy Common STock)
Robert W. Cook	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	45,000	45,000	-		-	Stock Option (Right to Buy Common Stock)
Steven W. Lefkowitz	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	16,000	211,379 (0%)	0%		0	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	40,000	40,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	14,000	106,052 (0%)	0%		0	Common Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	40,000	40,000	-		-	Stock Option (Right to Buy Common Stock)
Gary Gelbfish	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	10,000	2,111,121 (2%)	0%		0	Common Stock
Mehmood Khan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	12,500	464,583 (0%)	0%		0	Common Stock
Mehmood Khan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	40,000	40,000	-		-	Stock Option (Right to Buy Common Stock)
Mehmood Khan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	10,000	10,000	-		-	Restricted Stock Units
Mehmood Khan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	2,500	2,500	-		-	Restricted Stock Units
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2018	225,000	225,000	-		-	Stock Option (Right to Buy Common Stock)
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Feb 2018	13,392	13,392	-		-	Phantom Stock
John L. Armstrong	Exec VP of Tech Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2017	18,028	38,861 (0%)	0%		0	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	31 Dec 2017	18,028	18,029	-		-	Restricted Stock Units
John L. Armstrong	Exec VP of Tech Operations	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	12 Dec 2017	20,833	20,833 (0%)	0%	0.5	10,000	Common Stock
Myron Kaplan	None	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	12 Dec 2017	104,166	284,166 (0%)	0%	0.5	50,000	Common Stock
Robert W. Cook	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	12 Dec 2017	52,083	102,083 (0%)	0%	0.5	25,000	Common Stock
Steven W. Lefkowitz	None	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	12 Dec 2017	135,416	195,379 (0%)	0%	0.5	65,000	Common Stock, $0.001 par value per share
Janet M. Dillione	None	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	12 Dec 2017	52,083	92,052 (0%)	0%	0.5	25,000	Common Stock
Gary Gelbfish	None	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	12 Dec 2017	52,083	2,101,121 (3%)	0%	0.5	25,000	Common Stock, $0.001 par value per share
Mehmood Khan	None	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	12 Dec 2017	52,083	452,083 (0%)	0%	0.5	25,000	Common Stock
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	12 Dec 2017	104,166	225,373 (0%)	0%	0.5	50,000	Common Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Nov 2017	15,625	0	-		-	Phantom Stock
Myron Kaplan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Nov 2017	5,000	5,000	-		-	Restricted Stock Units
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.42 per share.	18 Aug 2017	36,207	121,207 (0%)	0%	0.4	15,026	Common Stock
Myron Kaplan	None	Purchase of securities on an exchange or from another person at price $ 0.40 per share.	17 Aug 2017	80,000	180,000 (0%)	0%	0.4	31,840	Common Stock
Myron Kaplan	None	Purchase of securities on an exchange or from another person at price $ 0.35 per share.	14 Aug 2017	50,000	100,000 (0%)	0%	0.3	17,400	Common Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Aug 2017	20,833	20,833	-		-	Phantom Stock
Mehmood Khan	None	Purchase of securities on an exchange or from another person at price $ 0.35 per share.	14 Aug 2017	50,000	50,000 (0%)	0%	0.4	17,500	Common Stock
Mehmood Khan	None	Purchase of securities on an exchange or from another person at price $ 0.42 per share.	14 Aug 2017	50,000	400,000 (0%)	0%	0.4	21,000	Common Stock
Mehmood Khan	None	Purchase of securities on an exchange or from another person at price $ 0.41 per share.	14 Aug 2017	150,000	350,000 (0%)	0%	0.4	61,500	Common Stock
Mehmood Khan	None	Purchase of securities on an exchange or from another person at price $ 0.39 per share.	14 Aug 2017	100,000	200,000 (0%)	0%	0.4	39,000	Common Stock
Mehmood Khan	None	Purchase of securities on an exchange or from another person at price $ 0.37 per share.	14 Aug 2017	50,000	100,000 (0%)	0%	0.4	18,500	Common Stock
Gary Gelbfish	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Aug 2017	75,000	75,000	-		-	Stock Option (right to buy)
Steven W. Lefkowitz	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jun 2017	75,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Mehmood Khan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	25 Jun 2017	75,000	75,000	-		-	Stock Option (Right to Buy Common Stock)
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.41 per share.	30 May 2017	7,550	182,371 (0%)	0%	0.4	3,133	Common Stock
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	17 May 2017	75,000	85,000 (0%)	0%	0.5	35,625	Common Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 May 2017	15,306	15,306	-		-	Phantom Stock
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	16 May 2017	50,000	174,821 (0%)	0%	0.5	24,000	Common Stock
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2017	15,306	15,306	-		-	Phantom Stock
Michael W. George	None	Purchase of securities on an exchange or from another person at price $ 0.50 per share.	15 May 2017	10,000	10,000 (0%)	0%	0.5	4,990	Common Stock
Myron Kaplan	None	Purchase of securities on an exchange or from another person at price $ 0.49 per share.	15 May 2017	30,000	50,000 (0%)	0%	0.5	14,820	Common Stock
Robert W. Cook	Chief Financial Officer	Purchase of securities on an exchange or from another person at price $ 0.50 per share.	15 May 2017	50,000	50,000 (0%)	0%	0.5	24,950	Common Stock
Janet M. Dillione	None	Purchase of securities on an exchange or from another person at price $ 0.48 per share.	15 May 2017	21,231	39,969 (0%)	0%	0.5	10,085	Common Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 May 2017	15,306	15,306	-		-	Phantom Stock
Taunia Markvicka	None	Purchase of securities on an exchange or from another person at price $ 0.51 per share.	15 May 2017	14,500	37,100 (0%)	0%	0.5	7,395	Common Stock
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.66 per share.	01 May 2017	4,800	124,821 (0%)	0%	0.7	3,156	Common Stock
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 1.66 per share.	30 Mar 2017	1,950	120,021 (0%)	0%	1.7	3,237	Common Stock
John L. Armstrong	Exec VP of Tech Operations	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2017	100,000	100,000	-		-	Stock Option (Right to Buy Common Stock)
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 2.10 per share.	28 Feb 2017	1,540	118,071 (0%)	0%	2.1	3,231	Common Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	20,714	20,714	-		-	Restricted Stock Units
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	40,000	40,000	-		-	Stock Option (Right to Buy Common Stock)
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	12,232	12,232	-		-	Restricted Stock Units
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	40,000	40,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	40,000	40,000	-		-	Stock Option (Right to Buy Common Stock)
Myron Kaplan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	10,000	10,000	-		-	Restricted Stock Units
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	15,357	15,357	-		-	Restricted Stock Units
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	40,000	40,000	-		-	Stock Option (Right to Buy Common Stock)
Taunia Markvicka	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	13,571	13,571	-		-	Restricted Stock Units
Taunia Markvicka	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Feb 2017	40,000	40,000	-		-	Stock Option (Right to Buy Common Stock)
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Feb 2017	3,472	3,472	-		-	Phantom Stock
Michael W. George	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Feb 2017	3,472	3,472	-		-	Phantom Stock
Janet M. Dillione	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Feb 2017	3,472	3,472	-		-	Phantom Stock
Antony Pfaffle	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.68 per share.	07 Feb 2017	10,000	10,000 (0%)	0%	0.7	6,800	Common Stock
Antony Pfaffle	Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	07 Feb 2017	10,000	70,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 2.00 per share.	07 Feb 2017	10,000	0 (0%)	0%	2	20,000	Common Stock
Robert W. Cook	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2017	185,000	185,000	-		-	Stock Option (Right to buy Common Stock)
Robert W. Cook	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2017	165,000	165,000	-		-	Stock Option (Right to buy Common Stock)
Judith Abrams	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2017	185,000	185,000	-		-	Stock Option (Right to buy Common Stock)
Judith Abrams	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Feb 2017	165,000	165,000	-		-	Stock Option (Right to buy Common Stock)
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 1.79 per share.	30 Jan 2017	1,780	116,531 (0%)	0%	1.8	3,183	Common Stock
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	30 Dec 2016	1,990	114,751	-		-	Common Stock
Khoso Baluch	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	09 Dec 2016	10,000	10,000	-		-	Common Stock
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	30 Nov 2016	1,800	112,761	-		-	Common Stock
Michael W. George	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Nov 2016	4,143	4,143	-		-	Phantom Stock
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Nov 2016	4,143	4,143	-		-	Common Stock
Janet M. Dillione	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Nov 2016	4,143	4,143	-		-	Phantom Stock
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Oct 2016	1,475	110,961	-		-	Common Stock
Antony Pfaffle	Director, Chief Scientific Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	21 Oct 2016	20,000	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Oct 2016	20,000	80,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Chief Scientific Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	21 Oct 2016	20,000	20,000	-		-	Common Stock, $0.001 par value per share
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2016	300,000	300,000	-		-	Stock Option (right to buy)
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2016	1,250,000	1,250,000	-		-	Stock Option (right to buy)
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2016	300,000	300,000	-		-	Stock Option (right to buy)
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2016	300,000	300,000	-		-	Stock Option (right to buy)
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2016	1,250,000	1,250,000	-		-	Stock Option (right to buy)
Khoso Baluch	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	03 Oct 2016	300,000	300,000	-		-	Stock Option (right to buy)
Taunia Markvicka	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	25 Aug 2016	18,600	22,600	-		-	Common Stock
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	19 Aug 2016	12,500	109,486	-		-	Common Stock
Myron Kaplan	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	19 Aug 2016	20,000	20,000	-		-	Common Stock
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Aug 2016	4,335	4,335	-		-	Phantom Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Aug 2016	4,335	4,335	-		-	Phantom Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Aug 2016	4,335	4,335	-		-	Phantom Stock
Randy Milby	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Aug 2016	50,000	246,243	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Aug 2016	100,000	157,026	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Aug 2016	50,000	0	-		-	Stock Option (right to buy)
Randy Milby	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Aug 2016	100,000	0	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2016	10,000	119,657	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2016	19,657	19,657	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 Jun 2016	819	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2016	19,657	100,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 Jun 2016	10,000	10,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 Jun 2016	9,657	10,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 Jun 2016	5,000	5,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 Jun 2016	7,181	2,819	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 Jun 2016	5,000	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 Jun 2016	2,000	819	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	15 Jun 2016	4,900	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2016	4,900	129,657	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	15 Jun 2016	4,900	4,900	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jun 2016	443	134,557	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jun 2016	5,000	5,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 Jun 2016	5,000	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jun 2016	443	443	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	10 Jun 2016	5,000	135,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	10 Jun 2016	443	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	09 Jun 2016	10,000	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jun 2016	10,000	140,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	09 Jun 2016	10,000	10,000	-		-	Common Stock, $0.001 par value per share
Janet M. Dillione	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	08 Jun 2016	3,738	18,738	-		-	Common Stock
Matthew Duffy	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	03 Jun 2016	46,106	28,571	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2016	100,000	217,399	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2016	100,000	0	-		-	Stock Option (right to buy)
Steven W. Lefkowitz	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 May 2016	7,800	159,599	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	27 May 2016	42,200	117,399	-		-	Common Stock, $0.001 par value per share
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	25 May 2016	8,600	96,986	-		-	Common Stock
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 May 2016	12,700	150,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	24 May 2016	12,700	12,700	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 May 2016	2,700	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 May 2016	5,000	2,700	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 May 2016	5,000	7,700	-		-	Common Stock, $0.001 par value per share
Matthew Duffy	None		24 May 2016	25,000	0	-		-	Warrant (right to purchase Common Stock)
Matthew Duffy	None		24 May 2016	21,454	74,677	-		-	Common Stock, $0.001 par value per share
Matthew Duffy	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 May 2016	1,153	1,153	-		-	Phantom Stock
Steven W. Lefkowitz	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 May 2016	15,126	167,399	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 May 2016	50,000	100,000	-		-	Stock Option (right to buy)
Steven W. Lefkowitz	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 May 2016	50,000	182,525	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 May 2016	14,874	132,525	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 May 2016	5,000	162,700	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 May 2016	10,000	10,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 May 2016	5,000	5,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 May 2016	3,201	6,799	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 May 2016	5,000	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 May 2016	400	6,399	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	20 May 2016	10,000	167,700	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	20 May 2016	6,399	0	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 May 2016	500	11,800	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2016	12,300	177,700	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	18 May 2016	12,300	12,300	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	18 May 2016	11,800	0	-		-	Common Stock, $0.001 par value per share
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2016	2,767	2,767	-		-	Phantom Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2016	2,767	2,767	-		-	Phantom Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2016	2,767	2,767	-		-	Phantom Stock
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 May 2016	20,000	40,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 May 2016	5,000	5,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2016	60,000	190,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	13 May 2016	60,000	60,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 May 2016	5,000	10,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 May 2016	5,000	15,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 May 2016	20,000	20,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	13 May 2016	5,000	0	-		-	Common Stock, $0.001 par value per share
Matthew Duffy	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 May 2016	1,153	1,153	-		-	Phantom Stock
Myron Kaplan	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Apr 2016	50,000	50,000	-		-	Stock Option (Right to buy Common Stock)
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2016	90,000	90,000	-		-	Stock Option (right to buy)
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2016	100,000	100,000	-		-	Stock Option (right to buy)
Steven W. Lefkowitz	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2016	75,000	75,000	-		-	Stock Option (right to buy)
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2016	95,000	95,000	-		-	Stock Option (Right to buy Common Stock)
Matthew Duffy	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2016	75,000	75,000	-		-	Stock Option (right to buy)
Taunia Markvicka	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	22 Feb 2016	90,000	90,000	-		-	Stock Option (right to buy)
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2016	3,968	3,968	-		-	Phantom Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2016	4,104	4,104	-		-	Phantom Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2016	3,831	3,831	-		-	Phantom Stock
Matthew Duffy	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Feb 2016	1,653	1,653	-		-	Phantom Stock
Steven W. Lefkowitz	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Feb 2016	30,000	147,399	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	04 Feb 2016	30,000	0	-		-	Stock Option (right to buy)
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Nov 2015	3,125	3,125	-		-	Phantom Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Nov 2015	3,645	3,645	-		-	Phantom Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Nov 2015	1,415	1,415	-		-	Phantom Stock
Matthew Duffy	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Nov 2015	594	594	-		-	Phantom Stock
Janet M. Dillione	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	22 Sep 2015	15,000	15,000	-		-	Common Stock
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Aug 2015	2,459	2,459	-		-	Phantom Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Aug 2015	2,868	2,868	-		-	Phantom Stock
Janet M. Dillione	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	12 Aug 2015	50,000	50,000	-		-	Stock Option (Right to buy Common Stock)
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	30 Jun 2015	1,610	57,026	-		-	Common Stock, $0.001 par value per share
Taunia Markvicka	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	23 Jun 2015	4,000	4,000	-		-	Common Stock
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Jun 2015	1,245	55,416	-		-	Common Stock, $0.001 par value per share
Matthew Duffy	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jun 2015	25,000	5,000	-		-	Stock Option (right to buy)
Matthew Duffy	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jun 2015	15,000	15,000	-		-	Stock Option (right to buy)
Matthew Duffy	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jun 2015	15,000	58,223	-		-	Common Stock, $0.001 par value per share
Matthew Duffy	None	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	02 Jun 2015	25,000	83,223	-		-	Common Stock, $0.001 par value per share
Matthew Duffy	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	02 Jun 2015	30,000	53,223	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2015	30,000	0	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	01 Jun 2015	30,000	30,000	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	01 Jun 2015	30,000	0	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	29 May 2015	1,026	54,171	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	28 May 2015	10,000	146,471	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Sale of securities on an exchange or to another person at price $ 0.00 per share.	28 May 2015	29,072	117,399	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None		23 Apr 2015	5,000	0	-		-	Warrant (right to purchase Common Stock)
Steven W. Lefkowitz	None		23 Apr 2015	19,536	0	-		-	Warrant (right to purchase Common Stock)
Steven W. Lefkowitz	None		23 Apr 2015	7,900	0	-		-	Warrant (right to purchase Common Stock)
Steven W. Lefkowitz	None		23 Apr 2015	32,436	156,471	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Apr 2015	730	52,166	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Apr 2015	979	53,145	-		-	Common Stock, $0.001 par value per share
Cora M. Tellez	None		01 Apr 2015	25,000	0	-		-	Common Stock Warrants (right to buy)
Cora M. Tellez	None		01 Apr 2015	25,000	88,386	-		-	Common Stock, $0.001 par value per share
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2015	50,000	50,000	-		-	Stock Option (right to buy)
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2015	50,000	50,000	-		-	Stock Option (right to buy)
Steven W. Lefkowitz	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2015	50,000	50,000	-		-	Stock Option (right to buy)
Matthew Duffy	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2015	50,000	50,000	-		-	Stock Option (right to buy)
Matthew Duffy	None		02 Mar 2015	4,884	0	-		-	Warrant (right to purchase Common Stock)
Matthew Duffy	None		02 Mar 2015	4,884	43,223	-		-	Common Stock, $0.001 par value per share
Taunia Markvicka	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Mar 2015	50,000	50,000	-		-	Stock Option (right to buy)
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	27 Feb 2015	1,211	51,436	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2015	75,000	75,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 Feb 2015	4,722	12,003	-		-	Common Stock, $0.001 par value per share
Antony Pfaffle	Director, Interim Chief Medical Officer	Sale of securities on an exchange or to another person at price $ 0.00 per share.	24 Feb 2015	12,003	0	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	24 Feb 2015	75,000	75,000	-		-	Stock Option (right to buy)
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2015	1,847	1,847	-		-	Phantom Stock
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2015	1,176	1,176	-		-	Phantom Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2015	2,873	2,873	-		-	Phantom Stock
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	13 Feb 2015	1,371	1,371	-		-	Phantom Stock
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	13 Feb 2015	1,911	50,225	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Dec 2014	2,016	48,314	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Dec 2014	3,272	46,298	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Dec 2014	4,734	43,026	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	10 Dec 2014	7,900	7,900	-		-	Warrant (right to purchase Common Stock)
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	28 Nov 2014	4,464	38,292	-		-	Common Stock, $0.001 par value per share
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	14 Nov 2014	4,205	4,205	-		-	Phantom Stock
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	14 Nov 2014	4,111	33,828	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Oct 2014	3,434	29,717	-		-	Common Stock, $0.001 par value per share
Cora M. Tellez	None		29 Oct 2014	5,000	0	-		-	Series C-3 Non-Voting Convertible Preferred Stock
Cora M. Tellez	None		29 Oct 2014	50,000	52,300	-		-	Common Stock, $0.001 par value per share
Cora M. Tellez	None	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	17 Oct 2014	2,100	2,300	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Oct 2014	4,058	26,283	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	30 Sep 2014	3,324	22,225	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Sep 2014	3,654	18,901	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	29 Aug 2014	3,125	15,247	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	15 Aug 2014	3,140	12,122	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	31 Jul 2014	6,250	8,982	-		-	Common Stock, $0.001 par value per share
Harry OGrady	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	21 Jul 2014	100,000	100,000	-		-	Stock Option (Right to Buy Common Stock)
Randy Milby	Director, Chief Executive Officer	Purchase of securities on an exchange or from another person at price $ 0.00 per share.	30 Jun 2014	2,732	2,732	-		-	Common Stock, $0.001 par value per share
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Apr 2014	15,000	15,000	-		-	Stock Option (right to buy)
Cora M. Tellez	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Apr 2014	30,000	30,000	-		-	Stock Option (right to buy)
Taunia Markvicka	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Apr 2014	30,000	30,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	02 Apr 2014	100,000	100,000	-		-	Stock Option (right to buy)
Michael W. George	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	28 Feb 2014	30,000	30,000	-		-	Stock Option (right to buy)
Steven W. Lefkowitz	Director, Interim Chief Financial Ofcr		17 Jan 2014	37,500	0	-		-	Warrant (right to purchase Common Stock)
Steven W. Lefkowitz	Director, Interim Chief Financial Ofcr		17 Jan 2014	87,500	0	-		-	Warrant (right to purchase Common Stock)
Steven W. Lefkowitz	Director, Interim Chief Financial Ofcr		17 Jan 2014	37,500	179,429	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	Director, Interim Chief Financial Ofcr	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	17 Jan 2014	5,468	173,961	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	Director, Interim Chief Financial Ofcr		17 Jan 2014	87,500	187,500	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	Director, Interim Chief Financial Ofcr	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	17 Jan 2014	12,759	174,741	-		-	Common Stock, $0.001 par value per share
Gary Gelbfish	None		17 Jan 2014	250,000	0	-		-	Warrant (right to purhcase Common Stock)
Gary Gelbfish	None		17 Jan 2014	250,000	724,382	-		-	Common Stock, $0.001 par value per share
Gary Gelbfish	None	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	17 Jan 2014	36,455	687,927	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer		17 Jan 2014	62,500	62,500	-		-	Warrant (right to purchase Common Stock)
Randy Milby	Director, Chief Executive Officer		17 Jan 2014	62,500	205,357	-		-	Common Stock, $0.001 par value per share
Randy Milby	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share.	17 Jan 2014	9,114	196,243	-		-	Common Stock, $0.001 par value per share
Steven W. Lefkowitz	Director, Interim Chief Financial Ofcr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	200,000	200,000	-		-	Stock Option (right to buy)
Steven W. Lefkowitz	Director, Interim Chief Financial Ofcr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	30,000	30,000	-		-	Stock Option (right to buy)
Gary Gelbfish	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	200,000	175,000	-		-	Stock Option (right to buy)
Gary Gelbfish	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	30,000	30,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	100,000	100,000	-		-	Stock Option (right to buy)
Antony Pfaffle	Director, Interim Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	30,000	30,000	-		-	Stock Option (right to buy)
Matthew Duffy	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	150,000	150,000	-		-	Stock Option (right to buy)
Matthew Duffy	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	30,000	30,000	-		-	Stock Option (right to buy)
Randy Milby	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jan 2014	100,000	100,000	-		-	Stock Option (right to buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

51.34% Fall from 52W High

High vol.+loss this week

Insider Trading disclosures for CorMedix Inc

The latest disclosure was made by Myron Kaplan in CorMedix Inc where a trade of 25,000 Common Stock done was reported to US exchanges on Jan. 17, 2025.

Screeners based on Insider Trading and SAST parameters